The Cystic Fibrosis Foundation has awarded $3 million to support a study of mental health among young children with…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
An infant boy, who was first seen with recurrent infections and a failure to thrive, was diagnosed with cystic…
SARS-CoV-2, the virus that causes COVID-19, appears to induce the loss of CFTR protein in a cell-based airway model, replicating…
Cystic Fibrosis Foundation (CFF) grants will help fund four programs that support the well-being of people with cystic…
CFTR correctors, such as elexacaftor, a component of the cystic fibrosis (CF) therapy Trikafta, may improve lung function…
The diversity and composition of bacteria in the gut of adults with cystic fibrosis (CF) differed significantly from that…
Biofilms of Pseudomonas aeruginosa visualized directly in sputum (phlegm) samples collected from children with cystic fibrosis (CF) did…
Two non-invasive tests — MRI scans and the lung clearance index (LCI) — were more sensitive to early lung…
A woman and her daughter were diagnosed with chronic rhinosinusitis, an inflammatory condition of the sinuses and nasal passages, with…
One year of Trikafta treatment improved lung function, reduced abnormalities in lung structure, and halted disease progression among school-age…